1/4/2021 6:49:24 AM
Pfizer: FDA Accepts For Filing The Initial BLA For Somatrogon To Treat Pediatric Patients With Growth Hormone Deficiency
12/31/2020 8:43:18 AM
Buffalo Bills And OPKO Health's BioReference Labs Initiate First Large Scale, Mandatory COVID-19 Fan Testing Program
10/9/2020 8:06:48 AM
OPKO Health's BioReference Laboratories Launches COVID-19 Testing Program For New York City Schools
9/2/2020 8:07:58 AM
OPKO Health's BioReference Labs Announces New York City Schools COVID-19 Testing Program
7/1/2020 8:23:07 AM
BioReference Lab Reports Results Of COVID-19 Molecular PCR Tests For Nursing Home And Live-in Facility Employees
6/9/2020 8:15:53 AM
OPKO Health Announces Japan Phase 3 Clinical Trial Met Its Primary And Secondary Objectives
6/1/2020 8:06:39 AM
OPKO Health Says FDA Authorizes Clinical Trial Evaluating RAYALDEE In COVID-19 Patients
5/13/2020 8:34:23 AM
OPKO Health's BioReference Labs, Westchester Medical Center Collaborate To Deliver Operational And Diagnostic Services
3/24/2020 9:11:46 AM
BioReference Laboratories Announces Collaboration With The City Of Miami To Provide COVID-19 Testing
8/29/2019 9:51:03 AM
OPKO Completes Pivotal Phase 3 Study For Somatrogon